Article
Sequence changes in the human adenovirus type 5 DNA polymerase associated with resistance to the broad spectrum antiviral cidofovir.
Antiviral research - 1 Oct 2002
Kinchington Paul R, Araullo-Cruz Trinita, Vergnes Jean-Paul, Yates Kathleen, Gordon Y Jerold
Abstract excerpt
Although there is currently no FDA approved antiviral treatment for adenovirus (Ad) infections, the broad spectrum antiviral cidofovir (CDV) has demonstrated potent inhibitory activity against many Ad serotypes in vitro and in an in vivo ocular replication model. The clinical potential of CDV prompted the assessment for the emergence of CDV resistance in Ad5. Serial passage of Ad5 in increasing concentrations of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
